mTOR Inhibitors: Past, Present and Future

The fifth and final pre-conference webinar, mTOR Inhibitors: Past, Present and Future, featuring moderator Elizabeth Skufca and presenters David Ritter, MD, PhD and Michael Wong, MD, PhD, will explore the evolution of mTOR inhibitors in treating TSC, from their discovery to current clinical use in managing SEGAs, kidney tumors, epilepsy, skin, and more. Learn about side effects, long-term outcomes, and what the future holds—including new research and emerging therapies.

Access the recording.

Access the slides from the webinar.

Learn more about the 2026 TSC World Conference.